|
ECO Animal Health Group PLC - Surrey, England-based pet and livestock pharmaceuticals - Confirms that it continues to trade in line with its revised revenue and margin expectations. Notes that this is despite difficult trading conditions due to ‘volatile’ pork prices and ‘cautious’ producers.
Says that a cash expenditure for its Research & Development portfolio representing 13% of annual revenue, a £8.7 million charge for early-stage technologies, as well as further investment in critical support functions are expected to result in earnings before interest, tax, depreciation, and amortization to come in 15% to 20% below consensus expectations for the year ending March 31.
Notes that it has no business in Ukraine and that annual revenue derived from Russia has historically been less than £500,000. Says it is currently exploring ways to recover a debt of €430,000 from one of its distributors in Russia.
Current stock price: 119.31 pence, down 21% on Tuesday
12-month change: down 68%
Copyright 2022 Alliance News Limited. All Rights Reserved.
|
